CeriBell, Inc.

NASDAQ:CBLL

Medical - Devices

Healthcare
$25.63 +1.42%

+$0.25 today

Market cap
$995.34M
Beta
0.84
P/E (TTM)
-10.9
EPS (TTM)
-$1.60
52W Low $10.85High $24.33

Volume 0.41M

Average 0.29M

CBLL Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

CeriBell, Inc.NASDAQ: CBLL

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 87.3%

Gross margin was 87.3% in Q1 FY2026, down 0.6 pp from a year earlier. On a trailing-twelve-month basis it was 87.7%, up 0.5 pp year over year. Over 3 fiscal years it widened by 5.0 pp.

Context

  • Gross margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
87.3%-0.1 pp QoQ
Last fiscal yearDec 2025
87.9%+1.2 pp YoY
LTMMar 2026
87.7%+0.5 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-0.6 pp——
1 year+1.2 pp——
3 years+5.0 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
87.9%
Year-over-year change
+1.2pp

Gross Margin vs competitors

How CBLL compares with its peers on the latest reported figures

  • CBLL's LTM Mar 2026 gross margin of 87.7% is the highest of the 7 companies compared; the peer median is 76.9%.
  • Its year-over-year change of +0.5 pp is the 5th highest of 7, against a peer median of +1.4 pp.
  • Over three fiscal years its change of +5.0 pp compares with a peer median of +3.6 pp.
CBLL Competitors Peer median
Gross Margin for CBLL and competitors
Company Period LTM level YoY 3-year change
CBLLCeriBell, Inc.LTM Mar 202687.7% +0.5 pp+5.0 pp
ECORelectroCore, Inc.LTM Mar 202687.2% +2.0 pp+5.6 pp
CVRXCVRx, Inc.LTM Mar 202685.5% +1.8 pp+7.6 pp
NPCENeuroPace, Inc.LTM Mar 202678.3% +3.5 pp+5.8 pp
BWAYBrainsWay Ltd.LTM Mar 202675.5% +1.0 pp+1.6 pp
LIVNLivaNova PLCLTM Sep 202667.9% -0.6 pp-1.5 pp
STIMNeuronetics, Inc.LTM Mar 202648.0% -15.6 pp-27.8 pp
Peer median (excluding CBLL) 76.9%+1.4 pp+3.6 pp

Competitors are the stored peer set for CBLL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue25.92M45.23M65.44M89.06M
Cost of Revenue4.43M7.06M8.69M10.79M
Gross Profit21.49M38.16M56.75M78.27M
Gross Margin82.9%84.4%86.7%87.9%
Research & Development7.24M9M13.56M19.14M
Selling, General & Admin50.27M59.21M82.9M117.53M
Operating Expenses57.51M68.2M96.46M136.68M
Depreciation & Amortization497K847K1.14M1.34M
EBITDA(35.06M)(26.51M)(37.32M)(50.18M)
EBITDA Margin-135.3%-58.6%-57.0%-56.3%
Operating Income(36.02M)(30.04M)(39.71M)(58.4M)
Operating Margin-139.0%-66.4%-60.7%-65.6%
Interest Income0000
Interest Expense1.6M2.1M1.99M1.89M
Other Income / Expenses(1.14M)588K(746K)4.99M
Income Before Tax(37.16M)(29.45M)(40.46M)(53.41M)
Pre-Tax Margin-143.4%-65.1%-61.8%-60.0%
Income Tax Expense2K11K00
Net Income(37.16M)(29.46M)(40.46M)(53.41M)
Net Margin-143.4%-65.1%-61.8%-60.0%
EPS (Basic)(1.59)(1.26)(3.39)(1.46)
EPS (Diluted)(1.59)(1.26)(3.39)(1.46)
Weighted Avg Shares23.32M23.32M11.95M36.54M
Weighted Avg Shares (Diluted)23.32M23.32M11.95M36.54M

CeriBell, Inc.

NASDAQ:CBLL

Intrinsic Alpha fair value

Locked

Current Price

$25.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.